 |
 |
 |
| Investments |
| • |
$5 million to $30 million |
| • |
Preferred equity or blend of securities |
| • |
Control to significant minority positions |
| • |
Buyout or growth capital |
| |
|
|
| Particular Areas of Interests |
| • |
Provider-based services |
| |
- |
Outpatient |
| |
- |
Primary care |
| • |
Outsourcing |
| • |
Distribution |
| |
- |
Specialty pharmacy |
| • |
Product companies with low technology risk |
| • |
Technology-enabled services |
| |
- |
Cost containment |
| |
- |
Information technology |
| |
- |
Records management |
| |
- |
Revenue cycle management |
| |
|
|
| Financial Profile |
| • |
Minimum revenue of $10 million |
| • |
Minimum EBITDA of $2 million |
| |
|
|
| Target Companies |
| • |
Established, profitable businesses addressing market opportunities with high growth characteristics |
| • |
Steady cash flowing businesses with compelling downside protection |
| • |
Selective, proven economic models that are positioned to reach profitability in the near future |
| |
|
| |
|
|
| Uses of Capital |
| • |
Buyout |
| • |
Organic growth |
| • |
Acquisition strategies or consolidation plays |
| • |
Recapitalizations (full or partial liquidity) |